Current therapeutic status of milrinone in CHF is:: (A) First choice drug for a patient of mild CHF, (B) As an add on drug to tide over the crisis in refractory CHF, (C) Best drug for long-term maintenance therapy of CHF, (D) Used only to suppress digitalis induced arrhythmias
Answer is B. None